5 completed. 5 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 4 | Completed 4 |
Follow Color Vision Defects: new trials by email Literature Review of Color Vision Defects trials Research Report on Color Vision Defects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patient-centered Modular CBT for CPTSD: A Randomised Controlled Pilot Study Psychotherapy - Complex Post-Traumatic Stress Disorder | Phase 1 / Phase 2 | Completed | Danish Veterans Centre | 60 | 2021-01-05 | 2025-04-02 |
| Gene Therapy for Achromatopsia (CNGA3) adeno-associated virus vector AAV- CNGA3 - Achromatopsia | Phase 1 / Phase 2 | Completed | MeiraGTx UK II Ltd | 11 | 2019-08-12 | 2022-12-01 |
| Gene Therapy for Achromatopsia (CNGB3) AAV - CNGB3 - Achromatopsia | Phase 1 / Phase 2 | Completed | MeiraGTx UK II Ltd | 23 | 2017-01-16 | 2023-03-08 |
| CNTF Implants for CNGB3 Achromatopsia NT-501 CNTF-releasing implant - Eye Disease, Achromatopsia | Phase 1 / Phase 2 | Completed | National Eye Institute (NEI) | 5 | 2012-07-01 | 2016-11-21 |
| Booster as an Adjunct to Internet-based Cognitive Behavior Therapy (CBT) Booster - Obsessive-compulsive Disorder | Phase 2 | Completed | Karolinska Institutet | 98 | 2012-02-01 | 2012-07-31 |
Eye Diseases (1) · Obsessive-Compulsive Disorder (1)
Cone Dystrophy (5) · Eye Diseases, Hereditary (5) · Nervous System Diseases (5) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Sensation Disorders (5) · Signs and Symptoms (5) · Vision Disorders (5) · Eye Diseases (4) · Anxiety Disorders (1) · Mental Disorders (1)
Immunization, Secondary (1) · Psychotherapy (1)
MeiraGTx UK II Ltd (2) · Danish Veterans Centre (1) · Karolinska Institutet (1) · National Eye Institute (NEI) (1)
United States (3) · United Kingdom (2) · Denmark (1) · Sweden (1)
James Bainbridge (1) · James Bainbridge, Prof (1) · Paul A Sieving, MD, PhD (1) · Sofie Folke, PhD (1)
2016 (1)